Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
about
Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10 cm: A Single-Institution Experience in China.Clinicopathological features and prognosis of small gastrointestinal stromal tumors outside the stomachRetrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.Genotype and risk of tumour rupture in gastrointestinal stromal tumour.Radiotherapy for Gastrointestinal Stromal Tumors.Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
P2860
Q36196622-31C41549-45B8-4597-9EE7-59B3B1CE1194Q36334621-B80ECDE6-1EC9-4ADB-B46A-5CB2B207721BQ37705793-273CE624-533F-4C0B-B1B5-67471A9A16B6Q38714790-FDBD04B9-2B51-414A-A087-668D6083BD44Q41812070-FBDB410A-FA3B-482A-8FA3-B99FB67A7F34Q48229455-9150A007-E55C-4B7C-9103-43EF6238BB61Q48536660-E0D91AF7-218D-4B1D-BD85-752B9F8122ECQ52583005-F4802845-7B54-4E2E-90A7-AB36DA95C72CQ53576519-3E0CB756-7E74-4B3B-BFFF-F11DE63E3403Q53822324-5877BC9A-BA4C-4565-AF8E-81DA556795F5
P2860
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@ast
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@en
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@nl
type
label
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@ast
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@en
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@nl
prefLabel
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@ast
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@en
Risk factors for gastrointesti ...... reated with adjuvant imatinib.
@nl
P2093
P2860
P50
P356
P1433
P1476
Risk factors for gastrointesti ...... treated with adjuvant imatinib
@en
P2093
Bengt Nilsson
Daniel Pink
Eva Wardelmann
Giuliano Ramadori
Jochen Schütte
Justus Duyster
Jörg T Hartmann
Kirsten Sundby Hall
Maarit Sarlomo-Rikala
Marcus Schlemmer
P2860
P304
P356
10.1002/CNCR.28669
P407
P577
2014-04-15T00:00:00Z